Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.3614
Abstract: 3614Background: NTRK gene fusions occur in diverse tumor types in adults and children. The selective TRK inhibitor, larotrectinib, has shown high response rates, durable disease control, and a favo... read more here.
Keywords: quality life; life adults; fusion cancer; children trk ... See more keywords